1. Report Scope and Methodology
1.1 Scope of the Report
1.2 Research Methodology
1.3 Executive Summary
2. Strategic Recommendations
3. Plasma Protein Therapeutics Market: Product Outlook
4. Global Plasma Protein Therapeutics Market: Sizing and Forecast
4.1 Global Plasma Protein Therapeutics Market Size, By Value, Year 2016-2026
Table 1: Global Plasma Protein Therapeutics Market Size, By Value, 2016-2026 (USD Million)
Table 2: Global Demand growth for immunoglobulin in select developed countries in 2018
Table 3: Global GDP per Capita Growth (annual %), 2015-2019
Table 4: World Population 65 Years & Above (% of Total), 2015-2019
Table 5: Global Current Healthcare Expenditure as % of GDP, 2015-2018 (In %
Table 6: Global Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
5. Global Plasma Protein Therapeutics Market Segmentation - By Product, By Application
5.1 Competitive Scenario of Global Plasma Protein Therapeutics Market: By Product
Table 7: Global Plasma Protein Therapeutics Market- By Product Market Share, 2020 & 2026
5.1.1 Immunoglobulin - Market Size and Forecast (2016-2026)
Table 8: Global Plasma Protein Therapeutics Market- By Immunoglobulin , By Value (USD Million), 2016-2026
5.1.2 Albumin - Market Size and Forecast (2016-2026)
Table 9: Global Plasma Protein Therapeutics Market- By Albumin, By Value (USD Million), 2016-2026
5.1.3 Factor VIII - Market Size and Forecast (2016-2026)
Table 10: Global Plasma Protein Therapeutics Market- By Factor VIII , By Value (USD Million), 2016-2026
5.1.4 Others - Market Size and Forecast (2016-2026)
Table 11: Global Plasma Protein Therapeutics Market- By Others, By Value (USD Million), 2016-2026
5.2 Competitive Scenario of Global Plasma Protein Therapeutics Market: By Application
Table 12: Global Plasma Protein Therapeutics Market- By Application Market Share, 2020 & 2026
5.2.1 Hemophilia - Market Size and Forecast (2016-2026)
Table 13: Global Plasma Protein Therapeutics Market- By Hemophilia, By Value (USD Million), 2016-2026
5.2.2 PID (Primary Immunodeficiency Disorder) - Market Size and Forecast (2016-2026)
Table 14: Global Plasma Protein Therapeutics Market- By PID, By Value (USD Million), 2016-2026
5.2.3 ITP (Idiopathic Thrombocytopenic Purpura) - Market Size and Forecast (2016-2026)
Table 15: Global Plasma Protein Therapeutics Market- By ITP, By Value (USD Million), 2016-2026
5.2.4 Others - Market Size and Forecast (2016-2026)
Table 16: Global Plasma Protein Therapeutics Market- By Others, By Value (USD Million), 2016-2026
6. Global Plasma Protein Therapeutics Market: Regional Analysis
6.1 Competitive Scenario of Global Plasma Protein Therapeutics Market : By Region
Table 17: Global Plasma Protein Therapeutics Market- By Region Market Share, 2020 & 2026
7. North America Plasma Protein Therapeutics Market: An Analysis (2016-2026)
7.1 North America Plasma Protein Therapeutics Market : Size and Forecast (2016-2026), By Value
Table 18: North America Plasma Protein Therapeutics Market Size, By Value, 2016-2026 (USD Million)
Table 19: North America Prevalence of Neurological Disorders, 2015-2019 (In Millions)
Table 20: North America Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Table 21: North America Prevalence of Total Cancer, 2015-2019 (In Millions)
7.2 North America Plasma Protein Therapeutics Market - Prominent Companies
7.3 Market Segmentation By Product (Immunoglobulin, Albumin, Factor VIII and Others)
Table 22: North America Plasma Protein Therapeutics Market- By Product, By Value (USD Million), 2016-2026
7.4 Market Segmentation By Application (Hemophilia, PID, ITP and Others)
Table 23: North America Plasma Protein Therapeutics Market- By Application, By Value (USD Million), 2016-2026
7.5 North America Plasma Protein Therapeutics Market: Country Analysis
7.6 Market Opportunity Chart of North America Plasma Protein Therapeutics Market - By Country, By Value, 2026
Table 24: Market Opportunity Chart of North America Plasma Protein Therapeutics Market- By Country, By Value (Year 2016-2026)
7.7 Competitive Scenario of North America Plasma Protein Therapeutics Market: By Country
Table 25: North America Plasma Protein Therapeutics Market- By Country Market Share, 2020 & 2026
7.8 United States Plasma Protein Therapeutics Market: Size and Forecast (2016-2026), By Value
Table 26: United States Plasma Protein Therapeutics Market Size, By Value, 2016-2026 (USD Million)
Table 27: United State Monthly Industry Aggregation Immunoglobulin (IG) Jan-June 2021 (In KG)
Table 28: United State Monthly Industry Aggregation Plasma Derived Factor VIII Jan-June 2021 (In KG)
Table 29: United State Monthly Industry Aggregation Albumin 25% Concentration Jan-June 2021 (In KG)
7.9 United States Plasma Protein Therapeutics Market Segmentation - By Product, By Application (2016-2026)
Table 30: United State Plasma Protein Therapeutics Market- By Product, By Value (USD Million), 2016-2026
Table 31: United State Plasma Protein Therapeutics Market- By Application, By Value (USD Million), 2016-2026
7.10 Canada Plasma Protein Therapeutics Market: Size and Forecast (2016-2026), By Value
Table 32: Canada Plasma Protein Therapeutics Market Size, By Value, 2016-2026 (USD Million)
Table 33: Canada Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Table 34: Canada Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Table 35: Canada Urban population, 2015-2019 (In %)
7.11 Canada Plasma Protein Therapeutics Market Segmentation - By Product, By Application (2016-2026)
Table 36: Canada Plasma Protein Therapeutics Market- By Product, By Value (USD Million), 2016-2026
Table 37: Canada Plasma Protein Therapeutics Market- By Application, By Value (USD Million), 2016-2026
8. Europe Plasma Protein Therapeutics Market: An Analysis (2016-2026)
8.1 Europe Plasma Protein Therapeutics Market : Size and Forecast (2016-2026), By Value
Table 38: Europe Plasma Protein Therapeutics Market Size, By Value, 2016-2026 (USD Million)
Table 39: Europe Monthly Distribution - IVIG, Jan-May 2021 (In KG)
Table 40: Europe Monthly Factor VIII Plasmatic SUPPLY ('000 i.u.), Jan-May 2021
Table 41: Europe Monthly Distribution Albumin 20 - 25% SUPPLY Jan-May 2021 (In KG)
8.2 Europe Plasma Protein Therapeutics Market - Prominent Companies
8.3 Market Segmentation By Product (Immunoglobulin, Albumin, Factor VIII and Others)
Table 42: Europe Plasma Protein Therapeutics Market- By Product, By Value (USD Million), 2016-2026
8.4 Market Segmentation By Application (Hemophilia, PID, ITP and Others)
Table 43: Europe Plasma Protein Therapeutics Market- By Application, By Value (USD Million), 2016-2026
8.5 Europe Plasma Protein Therapeutics Market: Country Analysis
8.6 Market Opportunity Chart of Europe Plasma Protein Therapeutics Market - By Country, By Value, 2026
Table 44: Market Opportunity Chart of Europe Plasma Protein Therapeutics Market- By Country, By Value (Year 2016-2026)
8.7 Competitive Scenario of Europe Plasma Protein Therapeutics Market: By Country
Table 45: Europe Plasma Protein Therapeutics Market- By Country Market Share, 2020 & 2026
8.8 Germany Plasma Protein Therapeutics Market: Size and Forecast (2016-2026), By Value
Table 46: Germany Plasma Protein Therapeutics Market Size, By Value, 2016-2026 (USD Million)
Table 47: Germany Monthly Distribution - IVIG, Jan-May 2021 (In KG)
Table 48: Germany Monthly Factor VIII Plasmatic SUPPLY ('000 i.u.), Jan-May 2021
Table 49: Germany Monthly Distribution Albumin 20 - 25% SUPPLY Jan-May 2021 (In KG)
8.9 Germany Plasma Protein Therapeutics Market Segmentation - By Product, By Application (2016-2026)
Table 50: Germany Plasma Protein Therapeutics Market- By Product, By Value (USD Million), 2016-2026
Table 51: Germany Plasma Protein Therapeutics Market- By Application, By Value (USD Million), 2016-2026
8.10 United Kingdom Plasma Protein Therapeutics Market: Size and Forecast (2016-2026), By Value
Table 52: United Kingdom Plasma Protein Therapeutics Market Size, By Value, 2016-2026 (USD Million)
Table 53: United Kingdom Monthly Distribution - IVIG, Jan-May 2021 (In KG)
Table 54: United Kingdom Monthly Factor VIII Plasmatic SUPPLY ('000 i.u.), Jan-May 2021
Table 55: United Kingdom Monthly Distribution Albumin 20 - 25% SUPPLY Jan-May 2021 (In KG)
8.11 United Kingdom Plasma Protein Therapeutics Market Segmentation - By Product, By Application (2016-2026)
Table 56: United Kingdom Plasma Protein Therapeutics Market- By Product, By Value (USD Million), 2016-2026
Table 57: United Kingdom Plasma Protein Therapeutics Market- By Application, By Value (USD Million), 2016-2026
8.12 France Plasma Protein Therapeutics Market: Size and Forecast (2016-2026), By Value
Table 58: France Plasma Protein Therapeutics Market Size, By Value, 2016-2026 (USD Million)
Table 59: France Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Table 60: France Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Table 61: France Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
8.13 France Plasma Protein Therapeutics Market Segmentation - By Product, By Application (2016-2026)
Table 62: France Plasma Protein Therapeutics Market- By Product, By Value (USD Million), 2016-2026
Table 63: France Plasma Protein Therapeutics Market- By Application, By Value (USD Million), 2016-2026
8.14 Spain Plasma Protein Therapeutics Market: Size and Forecast (2016-2026), By Value
Table 64: Spain Plasma Protein Therapeutics market Size, By Value, 2016-2026 (USD Million)
Table 65: Spain Monthly Distribution - IVIG, Jan-May 2021 (In KG)
Table 66: Spain Monthly Factor VIII Plasmatic SUPPLY ('000 i.u.), Jan-May 2021 (In KG)
Table 67: Spain Monthly Distribution Albumin 20 - 25% SUPPLY (Kgs) Jan-May 2021 (In KG)
8.15 Spain Plasma Protein Therapeutics Market Segmentation - By Product, By Application (2016-2026)
Table 68: Spain Plasma Protein Therapeutics Market- By Product, By Value (USD Million), 2016-2026
Table 69: Spain Plasma Protein Therapeutics Market- By Application, By Value (USD Million), 2016-2026
9. Asia Pacific Plasma Protein Therapeutics Market: An Analysis (2016-2026)
9.1 Asia Pacific Plasma Protein Therapeutics Market : Size and Forecast (2016-2026), By Value
Table 70: Asia Pacific Plasma Protein Therapeutics Market Size, By Value, 2016-2026 (USD Million)
Table 71: Asia Pacific Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Table 72: Asia Pacific Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Table 73: Asia Pacific Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
9.2 Asia Pacific Plasma Protein Therapeutics Market - Prominent Companies
9.3 Market Segmentation By Product (Immunoglobulin, Albumin, Factor VIII and Others)
Table 74: Asia Pacific Plasma Protein Therapeutics Market- By Product, By Value (USD Million), 2016-2026
9.4 Market Segmentation By Application (Hemophilia, PID, ITP and Others)
Table 75: Asia Pacific Plasma Protein Therapeutics Market- By Application, By Value (USD Million), 2016-2026
9.5 Asia Pacific Plasma Protein Therapeutics Market: Country Analysis
9.6 Market Opportunity Chart of Asia Pacific Plasma Protein Therapeutics Market - By Country, By Value, 2026
Table 76: Market Opportunity Chart of APAC Plasma Protein Therapeutics Market- By Country, By Value (Year-2026)
9.7 Competitive Scenario of Asia Pacific Plasma Protein Therapeutics Market: By Country
Table 77: APAC Plasma Protein Therapeutics Market- By Country Market Share, 2020 & 2026
9.8 China Plasma Protein Therapeutics Market: Size and Forecast (2016-2026), By Value
Table 78: China Plasma Protein Therapeutics Market Size, By Value, 2016-2026 (USD Million)
Table 79: China Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Table 80: China Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Table 81: China Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
9.9 China Plasma Protein Therapeutics Market Segmentation - By Product, By Application (2016-2026)
Table 82: China Plasma Protein Therapeutics Market- By Product, By Value (USD Million), 2016-2026
Table 83: China Plasma Protein Therapeutics Market- By Application, By Value (USD Million), 2016-2026
9.10 Japan Plasma Protein Therapeutics Market: Size and Forecast (2016-2026), By Value
Table 84: Japan Plasma Protein Therapeutics Market Size, By Value, 2016-2026 (USD Million)
Table 85: Japan Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Table 86: Japan Current Healthcare Expenditure as percentage of GDP, 2015-2018 (In %)
Table 87: Japan Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
9.11 Japan Plasma Protein Therapeutics Market Segmentation - By Product, By Application (2016-2026)
Table 88: Japan Plasma Protein Therapeutics Market- By Product, By Value (USD Million), 2016-2026
Table 89: Japan Plasma Protein Therapeutics Market- By Application, By Value (USD Million), 2016-2026
9.12 Australia Plasma Protein Therapeutics Market: Size and Forecast (2016-2026), By Value
Table 90: Australia Plasma Protein Therapeutics market Size, By Value, 2016-2026 (USD Million)
Table 91: Australia Current Healthcare Expenditure Per Capita, 2015-2018 (Current USD)
Table 92: Australia Current Healthcare Expenditure as percentage of GDP, 2015-2018 (In %)
Table 93: Australia Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
9.13 Australia Plasma Protein Therapeutics Market Segmentation - By Product, By Application (2016-2026)
Table 94: Australia Plasma Protein Therapeutics Market- By Product, By Value (USD Million), 2016-2026
Table 95: Australia Plasma Protein Therapeutics Market- By Application, By Value (USD Million), 2016-2026
9.14 South Korea Plasma Protein Therapeutics Market: Size and Forecast (2016-2026), By Value
Table 96: South Korea Plasma Protein Therapeutics Market Size, By Value, 2016-2026 (USD Million)
Table 97: South Korea Current Healthcare Expenditure Per Capita, 2015-2018 (In Numbers)
Table 98: South Korea Current Healthcare Expenditure as % of GDP, 2015-2018 (In %)
Table 99: South Korea Domestic Private Health Expenditure as % of Current Health Expenditure, 2015-2018 (In %)
9.15 South Korea Plasma Protein Therapeutics Market Segmentation - By Product, By Application (2016-2026)
Table 100: South Korea Plasma Protein Therapeutics Market- By Product, By Value (USD Million), 2016-2026
Table 101: South Korea Plasma Protein Therapeutics Market- By Application, By Value (USD Million), 2016-2026
10. Global Plasma Protein Therapeutics Market Dynamics
10.1 Drivers
10.2 Restraints
10.3 Trends
11. Market Attractiveness
11.1 Market Attractiveness Chart of Global Plasma Protein Therapeutics Market - By Product, 2026
Table 102: Market Attractiveness Chart of Global Plasma Protein Therapeutics Market- By Product (Year-2016-2026)
11.2 Market Attractiveness Chart of Global Plasma Protein Therapeutics Market - By Application, 2026
Table 103: Market Attractiveness Chart of Global Plasma Protein Therapeutics Market- By Application (Year 2016-2026
11.3 Market Attractiveness Chart of Global Plasma Protein Therapeutics Market - By Region, 2026
Table 104: Market Attractiveness Chart of Global Plasma Protein Therapeutics Market- By Region (Year 2016-2026)
12. Competitive Landscape
12.1 Major Technological Innovations, Mergers & Acquisitions and Role of Manufacturers
12.2 Product Pipeline of Leading Plasma Protein Therapeutics Companies
12.3 Market Share Analysis
Table 105: Global Plasma Protein Therapeutics company market share (%), 2020
13. Company Analysis
13.1 CSL Behring
Table 106: CSL Behring Sales Revenues, 2016-2019 (USD Million)
Table 107: CSL Behring Net Profit, 2016-2019 (USD Million)
Table 108: CSL Behring Sales Revenue Split, By Business Segment (%), FY2019
Table 109: CSL Behring Sales Revenue Split, By Geography Segment (%), FY2019
13.2 Baxter International Inc.
Table 110: Baxter International Inc. Sales Revenues, 2016-2020 (USD Million)
Table 111: Baxter International Inc. Gross Profit, 2016-2020 (USD Million)
Table 112: Baxter International Inc. Sales Revenue Split, By Business Segment (%), FY2020
Table 113: Baxter International Inc. Sales Revenue Split, By Geography Segment (%), FY2020
13.3 Takeda Pharmaceutical Company Limited
Table 114: Takeda Pharmaceutical Company Limited Sales Revenues, 2016-2020 (USD Million)
Table 115: Takeda Pharmaceutical Company Limited Net Income, 2016-2020 (USD Million)
Table 116: Takeda Pharmaceutical Company Limited Sales Revenue Split, By Business Segment (%), FY2020
Table 117: Takeda Pharmaceutical Company Limited Sales Revenue Split, By Geography Segment (%), FY2020
13.4 Biotest AG
Table 118: Biotest AG Sales Revenues, 2016-2020 (USD Million)
Table 119: Biotest AG Gross Profit, 2016-2020 (USD Million)
Table 120: Biotest AG Sales Revenue Split, By Business Segment (%), FY2020
Table 121: Biotest AG Sales Revenue Split, By Geography Segment (%), FY2020
13.5 Bayer Group
Table 122: Bayer Group Sales Revenues, 2016-2020 (USD Million)
Table 123: Bayer Group Net Profit, 2016-2020 (USD Million)
Table 124: Bayer Group, By Business Segment (%), FY2020
Table 125: Bayer Group, By Geographical Segment (%), FY2020
13.6 Grifols, S.A.
Table 126: Grifols, S.A. Sales Revenues, 2016-2020 (USD Million)
Table 127: Grifols, S.A. Sales Revenue Split, By Business Segment (%), FY2020
Table 128: Grifols, S.A. Sales Revenue Split, By Business Segment (%), FY2020
13.7 Pfizer
Table 129: Pfizer Annual Sales Revenue (USD Million), 2016-2020
Table 130: Pfizer Annual Net Income/Loss (USD Million), 2016-2020
Table 131: Pfizer sales Revenue, By Geographical Segment (%), FY2020
13.8 OCTA Pharma
Table 132: Octapharma USA Inc. Sales Revenues, 2016-2020 (USD Million)
Table 133: Octapharma USA Inc. Net Profit, 2016-2020 (USD Million)
13.9 Kedrion bio Pharma
Table 134: Kedrion Biopharma Sales Revenues, 2016-2020 (USD Million)
Table 135: Kedrion Biopharma Sales Revenue Split, By Geography Segment (%), FY2020
13.10 ADMA biologics, Inc.
Table 136: ADMA Biologics, Inc. Sales Revenues, 2016-2020 (USD Million)
Table 137: ADMA Biologics, Inc. Sales Revenue Split, By Business Segment (%), FY2020